Taking Advantage of the Selectivity of Histone Deacetylases and Phosphodiesterase Inhibitors to Design Better Therapeutic Strategies to Treat Alzheimer's Disease.

Cuadrado-Tejedor, Mar; Pérez-González, Marta; García-Muñoz, Cristina; Muruzabal, Damián; García-Barroso, Carolina; Rabal, Obdulia; Segura, Víctor; Sánchez-Arias, Juan A; Oyarzabal, Julen; Garcia-Osta, Ana

Cuadrado-Tejedor, Mar; Pérez-González, Marta; García-Muñoz, Cristina; Muruzabal, Damián; García-Barroso, Carolina; Rabal, Obdulia; Segura, Víctor; Sánchez-Arias, Juan A; Oyarzabal, Julen; Garcia-Osta, Ana.

Afiliação

Cuadrado-Tejedor M; Neurobiology of Alzheimer's Disease, Neurosciences Program, Center for Applied Medical Research (CIMA), University of Navarra, Pamplona, Spain.
Pérez-González M; Department of Pathology, Anatomy and Physiology, School of Medicine, University of Navarra, Pamplona, Spain.
García-Muñoz C; Health Research Institute of Navarra (IDISNA), Pamplona, Spain.
Muruzabal D; Neurobiology of Alzheimer's Disease, Neurosciences Program, Center for Applied Medical Research (CIMA), University of Navarra, Pamplona, Spain.
García-Barroso C; Department of Pathology, Anatomy and Physiology, School of Medicine, University of Navarra, Pamplona, Spain.
Rabal O; Health Research Institute of Navarra (IDISNA), Pamplona, Spain.
Segura V; Neurobiology of Alzheimer's Disease, Neurosciences Program, Center for Applied Medical Research (CIMA), University of Navarra, Pamplona, Spain.
Sánchez-Arias JA; Neurobiology of Alzheimer's Disease, Neurosciences Program, Center for Applied Medical Research (CIMA), University of Navarra, Pamplona, Spain.
Oyarzabal J; Neurobiology of Alzheimer's Disease, Neurosciences Program, Center for Applied Medical Research (CIMA), University of Navarra, Pamplona, Spain.
Garcia-Osta A; Small Molecule Discovery Platform, Molecular Therapeutics Program, Center for Applied Medical Research (CIMA), University of Navarra, Pamplona, Spain.